TNFRSF13C and in situ carcinoma: To determine if the decreased BAFF-R expression is stable over time, BAFF-R levels were assessed in samples collected longitudinally from CIS patients participating in the PhoCIS trial (24) and a limited change in BAFF-R expression was observed over a three-month study period (Figures 4G, H).